Precautions for indicating non-steroidal anti-inflammatory to control dental pain in patients with COVID-19

2021, Number 4

Rev Cubana Estomatol 2021; 58 (4)

Falcón GBE, Falcón PGS

Language: Spanish
References: 5
Page:
PDF size: 189.32 Kb.

Text Extraction

No abstract.

REFERENCES

Basille D, Plouvier N, Trouve C, Duhaut P, Andrejak C, Jounieaux V. Non-steroidal Anti-inflammatory Drugs may Worsen the Course of Community-Acquired Pneumonia: A Cohort Study. Lung. 2017;195(2):201-8. DOI: 10.1007/s00408-016-9973-1
Sodhi M, Khosrow-Khavar F, FitzGerald JM, Etminan M. Non-steroidal Anti-inflammatory Drugs and the Risk of Pneumonia Complications: A Systematic Review. Pharmacotherapy. 2020;40(9):970-7. DOI: 10.1002/phar.2451
Russell B, Moss C, Rigg A, Van Hemelrijck M. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting? Ecancermedicalscience. 2020;14:1023. PMCID: PMC7105332
FitzGerald GA. Misguided drug advice for COVID-19. Science. 2020;367(6485):1434. DOI: 10.1126/science.abb8034
Bruce E, Barlow-Pay F, Short R, Vilches-Moraga A, Angeline Price A, McGovern A, et al. Prior Routine Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Important Outcomes in Hospitalised Patients with COVID-19. J Clin Med. 2020;9(8):E2586. PMCID: PMC746519